BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Max-Planck-Institute for Immunobiology 

Stübeweg 51

Freiburg    D - 79108  Germany
Phone: 49-0-761-510-8-541 Fax: 49-0-761-5108-545


SEARCH JOBS










 Company News
Max Planck Institute Takes Delivery Of Waters Corporation (WAT) Synapt High Definition MS System 1/8/2007 3:44:19 PM
454 Life Sciences And Max Planck Institute To Sequence Neandertal Genome 7/20/2006 3:18:48 PM
Max-Planck Researchers Fuse Nerve Tissue With Computer Chips 6/2/2006 1:32:36 PM
New Potential Drug Target In Tuberculosis 5/30/2006 12:55:10 PM
A Tumor Suppressor In Mice And Men 5/30/2006 12:54:07 PM
Max Planck Institute Purchases Rock Maker And Rock Imager 24 From Formulatrix For Automation Of Protein Crystallization10/19/2005 5:11:57 PM
Perlegen Sciences, Inc., Max Planck Institute For Developmental Biology, And Salk Institute For Biological Studies To Collaborate On Arabidopsis DNA Variation Study10/19/2005 5:11:45 PM
Pintex Pharmaceuticals, Inc. Acquires Worldwide Rights To Pin1 Related Technology From Max Planck Society; Will Enhance Pintex's Ability To Develop Cancer Therapies And Diagnostics10/19/2005 5:10:47 PM
Prof. Dr. Bernhard Scholkopf, Max Plank Director, Named To Health Discovery Corporation (DWCM.OB) Scientific Advisory Board10/19/2005 5:10:22 PM
Ingenium Pharmaceuticals Signs INGENOtyping(TM) Agreement With Max-Planck-Institute for Immunobiology10/19/2005 5:09:33 PM
12